TYMP

Chr 22AR

thymidine phosphorylase

Also known as: ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF

The protein encoded by this gene functions as an angiogenic factor that specifically promotes blood vessel formation by stimulating endothelial cell growth. Mutations cause mitochondrial DNA depletion syndrome 1 (MNGIE type), also known as mitochondrial neurogastrointestinal encephalomyopathy, which is inherited in an autosomal recessive pattern. The pathogenic mechanism involves dominant negative effects that disrupt normal mitochondrial DNA maintenance.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, Mechanism
MultiplemechanismARLOEUF 0.921 OMIM phenotype
Clinical SummaryTYMP
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
19 unique Pathogenic / Likely Pathogenic· 48 VUS of 100 total submissions
📖
GeneReview available — TYMP
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.92LOEUF
pLI 0.000
Z-score 1.82
OE 0.52 (0.320.92)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.10Z-score
OE missense 1.02 (0.921.12)
276 obs / 271.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.52 (0.320.92)
00.351.4
Missense OE1.02 (0.921.12)
00.61.4
Synonymous OE1.09
01.21.6
LoF obs/exp: 9 / 17.1Missense obs/exp: 276 / 271.5Syn Z: -0.79
DN
0.73top 25%
GOF
0.6541th %ile
LOF
0.2583th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic16
VUS48
Likely Benign31
Benign1
Conflicting1
3
Pathogenic
16
Likely Pathogenic
48
VUS
31
Likely Benign
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
0
0
0
3
Likely Pathogenic
13
3
0
0
16
VUS
0
41
3
4
48
Likely Benign
0
1
15
15
31
Benign
1
0
0
0
1
Conflicting
1
Total17451819100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TYMP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →